Why Siloed Commercial Forecasting Fails Oncology Teams: Stelios Tzellos, PhD, Makes the Case for Science-First Market Intelligence
LONDON, United Kingdom, Jul 18, 2026, ZEX PR WIRE — In pharmaceutical commercial planning, the analytical tools available to forecasting teams have grown considerably more sophisticated. Models are more precise. Datasets are larger. The methodological standards underpinning commercial strategy have matured with each planning cycle. But there is a persistent structural problem in many......
